allograft

(redirected from allograft rejection)
Also found in: Dictionary, Thesaurus, Medical.

allograft:

see transplantation, medicaltransplantation, medical,
surgical procedure by which a tissue or organ is removed and replaced by a corresponding part, usually from another part of the body or from another individual.
..... Click the link for more information.
.

allograft

[′a·lō‚graft]
(biology)
Graft from a donor transplanted to a genetically dissimilar recipient of the same species. Also known as allogeneic graft.
References in periodicals archive ?
Transbronchial biopsy to obtain lung tissue is currently the gold standard to assess patients for lung allograft rejection and to distinguish rejection from its clinical mimics such as aspiration, infection, drug toxicity, and recurrent disease.
Pancreas allograft rejection was treated by anti-thymocyte globulin, pulse steroid therapy, and increasing the dose of maintenance immunosuppressive medications.
Taking into account the importance of IL-18 and CD40 in T cell activation and important role of t-cell activation in kidney allograft rejection, the aim of the present study was to investigate the association of single nucleotide polymorphisms (SNP) in the genes of these two molecules with allograft rejection in kidney transplant recipients.
Other studies have also shown favorable results in heart transplant recipients including reversal of allograft rejection episodes and tapering of immunosuppressive drugs (36-38).
An open incisional biopsy was taken from the transplanted kidney to assess for possible ongoing allograft rejection.
Maintenance immunosuppression and the intensity of clinical follow-up should be reevaluated after symptomatic or asymptomatic late acute heart allograft rejection.
Late-acute renal allograft rejection and symptomless Cytomegalovirus infection.
Obliterative bronchiolitis, also known as bronchiolitis obliterans or OB, is a direct manifestation of chronic or acute allograft rejection.
Tacrolimus is reportedly a leading immunosuppression drug used for the prevention of transplant allograft rejection after organ transplantation.
For that application, early studies identified 40 mRNA transcripts derived from PBCs with a favorable dynamic range, differential expression in patients with and without allograft rejection, and regression of pathologic expression in association with histologic regression (4).